$HIMS (-1,68 %) currently sells Compounted Semaglutide, which is still on the FDA shortlist, only Tirzepatide ($LLY (+1,78 %) GLP-1) was removed from the FDA shortage list yesterday!
However, HIMS is already planning to sell Compounded Liraglutide (a generic drug that is 100% legal to manufacture even without shortage) in 2025, which is just beginning, and thus become independent of Lilly and $NOVO B (-17,74 %) and
But: HIMS does not sell branded GLP-1 and offers semaglutide in a compounded version, which is considered the second best drug. Liraglutide, which HIMS could also offer, is off-patent but works significantly worse (only 12% weight loss compared to 15% for semaglutide). Tirzepatide is considered the best drug by Lilly.
Have 30% of my Net Worth in Hims, and have set the next limit buy at 20€, would love some Getquin Coins! ;)
